Y. Wang

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

M. Suarez‐Almazor, M. Lacouture, I. Puzanov, 2017, Journal of Immunotherapy for Cancer.

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: Review of the literature and personalized risk-based prevention strategy.

J. Larkin, S. Peters, I. Puzanov, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts

R. Bast, W. Liao, M. N. Sutton, 2015, Cell Death and Disease.

Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen‐induced late phase cutaneous responses in atopic subjects

S. Phipps, R. de Waal Malefyt, A. Kay, 2009, Allergy.